These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8674804)

  • 1. Comparison of roxatidine and famotidine on nocturnal gastric juice secretion.
    Tanioka H; Kaga K
    J Int Med Res; 1996; 24(1):88-91. PubMed ID: 8674804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiographic assessment of nocturnal gastric juice secretion after administration of roxatidine acetate hydrochloride.
    Tanioka H; Terahara A; Sasaki Y
    Clin Ther; 1991; 13(1):22-4. PubMed ID: 1674230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
    Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
    J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Famotidine for gastric radiography.
    Tanioka H; Araki T; Sasaki Y; Yoshikawa K
    Radiat Med; 1993; 11(1):12-6. PubMed ID: 8516448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
    Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the efficacy of famotidine (Quamatel) in the complex treatment of erosive gastroduodenitis, stress stomach ulcer and peptic duodenal ulcer].
    Korukov B; Ognianov S; Kostadinova R; Gerzilov P; Ivanov A; Iarŭmov N
    Khirurgiia (Sofiia); 2004; 60(1):4-7. PubMed ID: 15704743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring].
    Rakov AL; Makarov IuS; Gorbakov VV; Mironenko DA; Golochalova TV
    Voen Med Zh; 2001 Sep; 322(9):54-8. PubMed ID: 11668793
    [No Abstract]   [Full Text] [Related]  

  • 8. Famotidine in the USA: a review of efficacy studies.
    Gitnick G
    J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of hypothiazide on gastric secretion in peptic ulcer].
    Orlikov GA; Makena VD
    Vrach Delo; 1980 Mar; (3):26-8. PubMed ID: 7376605
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N
    Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roxatidine acetate as maintenance treatment for patients with peptic ulcer disease. The European Cooperative Roxatidine Study Group.
    Clin Ther; 1991; 13(1):47-57. PubMed ID: 1674231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects.
    Thomson AB; Pinchbeck BR; Kirdeikis J; Zuk L; Marriage B; Prat A
    Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lafutidine can improve the quality of gastric ulcer healing in humans: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Oshitani N; Fujiwara Y; Arakawa T
    Inflammopharmacology; 2006 Dec; 14(5-6):226-30. PubMed ID: 17186182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer].
    Pal'tsev AI; Maslennikova TA
    Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
    Dallera F; Scanzi G; Gendarini A
    Clin Ter; 1994 Jan; 144(1):23-6. PubMed ID: 8168347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sucralfate: the agent of choice in the treatment of peptic ulcer?].
    Fedorov NE; Laktionova AA; Tkachev AV; Iakovlev AA; Soboleva LV; Grib VM
    Ter Arkh; 1990; 62(2):64-7. PubMed ID: 2186496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotherapy of non-associated with Helicobacter pylori ulcer].
    Grinevich VB; Uspenskiĭ IuP; Shabanova GZh; Sablin OA; Shcherbina NN
    Klin Med (Mosk); 2002; 80(10):44-6. PubMed ID: 12471838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combined use of roxatidine and pirenzepine on gastric secretion in humans.
    Misawa T; Chijiiwa Y; Yoshida K; Tanaka A; Kabemura T; Fujishima H; Harada N; Nawata H
    Fukuoka Igaku Zasshi; 1990 Jul; 81(7):242-6. PubMed ID: 1976580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, randomized trial of roxatidine 150 mg in the early evening versus bedtime administration in the short-term treatment of duodenal ulcer.
    Lazzaroni M; Canali A; Bianchi Porro G
    Aliment Pharmacol Ther; 1995 Aug; 9(4):425-31. PubMed ID: 8527619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.